Du Liubing, Xie Yanchun, Zheng Kai, Wang Niu, Gao Mingcheng, Yu Ting, Cao Liu, Shao QianQian, Zou Yong, Xia Wei, Fang Qianglin, Zhao Bo, Guo Deyin, Peng Xiaoxue, Pan Ji-An
The Center for Infection and Immunity Study and Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, No. 66, Gongchang Road, Guangming District, Shenzhen, Guangdong, 518107, China.
School of Public Health (Shenzhen), Sun Yat-sen University, Guangming Science City, Shenzhen, 518107, China.
Redox Biol. 2021 Nov 26;48:102199. doi: 10.1016/j.redox.2021.102199.
3CLpro is a key proteinase for SARS-CoV-2 replication and serves as an important target for antiviral drug development. However, how its activity is regulated intracellularly is still obscure. In this study, we developed a 3CLpro protease activity reporter system to examine the impact of various factors, including nutrient supplements, ions, pHs, or oxidative stress inducers, on 3CLpro protease activity. We found that oxidative stress could increase the overall activity of 3CLpro. Not altering the expression, oxidative stress decreased the solubility of 3CLpro in the lysis buffer containing 1% Triton-X-100. The Triton-X-100-insoluble 3CLpro was correlated with aggregates' formation and responsible for the increased enzymatic activity. The disulfide bonds formed between Cys85 sites of 3CLpro protomers account for the insolubility and the aggregation of 3CLpro. Besides being regulated by oxidative stress, 3CLpro impaired the cellular antioxidant capacity by regulating the cleavage of GPx1 at its N-terminus. This cleavage could further elevate the 3CLpro-proximate oxidative activity, favor aggregation and activation of 3CLpro, and thus lead to a positive feedback loop. In summary, we reported that oxidative stress transforms 3CLpro into a detergent-insoluble form that is more enzymatically active, leading to increased viral replication/transcription. Our study provided mechanistic evidence that suggests the therapeutic potential of antioxidants in the clinical treatment of COVID-19 patients.
3C样蛋白酶(3CLpro)是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制的关键蛋白酶,也是抗病毒药物研发的重要靶点。然而,其在细胞内的活性是如何被调控的仍不清楚。在本研究中,我们开发了一种3CLpro蛋白酶活性报告系统,以检测各种因素,包括营养补充剂、离子、pH值或氧化应激诱导剂,对3CLpro蛋白酶活性的影响。我们发现氧化应激可增加3CLpro的整体活性。在不改变其表达的情况下,氧化应激降低了3CLpro在含有1% Triton-X-100的裂解缓冲液中的溶解度。不溶于Triton-X-100的3CLpro与聚集体的形成相关,并导致酶活性增加。3CLpro原体的半胱氨酸85位点之间形成的二硫键导致了3CLpro的不溶性和聚集。除了受氧化应激调控外,3CLpro还通过调节谷胱甘肽过氧化物酶1(GPx1)N端的切割来损害细胞抗氧化能力。这种切割可进一步提高3CLpro附近的氧化活性,有利于3CLpro的聚集和激活,从而导致正反馈循环。总之,我们报道氧化应激将3CLpro转变为一种更具酶活性的不溶于去污剂的形式,导致病毒复制/转录增加。我们的研究提供了机制证据,表明抗氧化剂在COVID-19患者临床治疗中的潜在治疗价值。